A Kaas
Overview
Explore the profile of A Kaas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gooijers J, Chalavi S, Koster L, Roebroeck A, Kaas A, Swinnen S
Cereb Cortex
. 2022 Jan;
32(17):3848-3863.
PMID: 35029640
Previous studies aimed to unravel a digit-specific somatotopy in the primary sensorimotor (SM1) cortex. However, it remains unknown whether digit somatotopy is associated with motor preparation and/or motor execution during...
2.
Kaas A, Pfleger C, Kharagjitsingh A, Schloot N, Hansen L, Buschard K, et al.
Diabet Med
. 2011 Dec;
29(6):734-41.
PMID: 22150609
Aims: The relation of disease progression and age, serum interleukin 10 (IL-10) and interferon gamma (IFNγ) and their genetic correlates were studied in paediatric patients with newly diagnosed Type 1...
3.
Kaas A, Pfleger C, Hansen L, Buschard K, Schloot N, Roep B, et al.
Clin Exp Immunol
. 2010 Jun;
161(3):444-52.
PMID: 20529086
The progression of type 1 diabetes after diagnosis is poorly understood. Our aim was to assess the relation of disease progression of juvenile-onset type 1 diabetes, determined by preserved beta...
4.
Pfleger C, Kaas A, Hansen L, Alizadeh B, Hougaard P, Holl R, et al.
Clin Immunol
. 2008 Apr;
128(1):57-65.
PMID: 18434252
Th1 related chemokines CCL3 and CCL5 and Th2 related CCL4 as ligands of the receptor CCR5 contribute to disease development in animal models of type 1 diabetes. In humans, no...
5.
Hartoft-Nielsen M, Rasmussen A, Kaas A, Feldt-Rasmussen U, Buschard K
Eur J Endocrinol
. 2004 Sep;
151(3):375-82.
PMID: 15362968
Objective: Changes in the functional state of beta cells by neonatal stimulation or adolescent suppression have reduced the incidence of type 1 diabetes mellitus in animal models. The aim of...
6.
Osterbye T, Jorgensen K, Fredman P, Tranum-Jensen J, Kaas A, Brange J, et al.
Glycobiology
. 2001 Jul;
11(6):473-9.
PMID: 11445552
Sulfatide is a glycolipid that has been associated with insulin-dependent diabetes mellitus. It is present in the islets of Langerhans and follows the same intracellular route as insulin. However, the...
7.
Hartoft-Nielsen M, Rasmussen A, Kaas A, Bock T, Buschard K, Feldt-Rasmussen U
Autoimmunity
. 2001 Mar;
33(2):79-84.
PMID: 11264786
Linomide is a potent immunomodulator and has been reported to prevent type 1 diabetes mellitus in non-obese diabetic (NOD) mice and to reduce the incidence of other autoimmune diseases in...
8.
Funda D, Kaas A, Bock T, Tlaskalova-Hogenova H, Buschard K
Diabetes Metab Res Rev
. 1999 Dec;
15(5):323-7.
PMID: 10585617
Background: Epidemiological as well as animal studies have shown that environmental factors such as nutrition contribute to the development of diabetes. In this study we investigated whether the early introduction...
9.
Buschard K, Schloot N, Kaas A, Bock T, Horn T, Fredman P, et al.
Diabetologia
. 1999 Oct;
42(10):1212-8.
PMID: 10525662
Aims/hypothesis: Sulphatide and insulin are present in the secretory granules and at the surface of beta cells in islets of Langerhans. Insulin autoantibodies and T-cell reactivity against insulin exist during...
10.
Strandell E, Kaas A, Hartoft-Nielsen M, Bock T, Buschard K, Bendtzen K
APMIS
. 1999 May;
107(4):413-9.
PMID: 10230696
We investigated whether cytokines produced primarily by monocytes/macrophages (IL-1alpha), Th1-lymphocytes (IFNgamma), or Th2-lymphocytes (IL-4) are modulated in diabetes-prone NOD mice by insulin treatment as used in prophylaxis studies. The cytokines...